Global Neurostimulation Devices Market - Forecasts from 2018 to 2023

The global neurostimulation devices market is estimated to register a CAGR of 10.29% over the forecast period of 2017-2023. Neurostimulation devices are implantable programmable medical devices that deliver electrical stimulation to specific parts of the patient's brain, spinal cord or peripheral nervous system for the treatment of various conditions such as chronic pain, movement disorders, epilepsy and Parkinson's disease. Neurostimulation is used as a key element in neural prosthetics for hearing aids, artificial vision, artificial limbs, brain-machine interfaces, etc. the growth in the neurostimulation devices market may be attributed to the increasing prevalence of chronic neuro-muscular disorder and rising adoption of these devices by the physicians. Recent advances in neurotechnologies and neuroimaging have resulted in rapid rise in the use of neurostimulation devices for the treatment of increasingly wide range of neurologic and psychiatric disorders thus, leading to the robust growth of the market for the given forecast period. However, stringent regulations pertaining to the neurostimulation devices and lack of skilled professionals for performing the surgeries might restrain the market growth during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global neurostimulation devices market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Neurostimulation Devices market.

Major industry players profiled as part of the report are William Demant Holding A/S, Medtronic and Cochlear Ltd. among others.

Segmentation

By Product

Neurostimulators
Implantable Cardiac Pacemakers
Cochlear Implants
Ventricular assist devices
Others

By End-Users

Hospitals and Clinics
Ambulatory Surgical Centers
Speciality Clinics

By Geography

North America

United States
Canada
Others

South America
Brazil
Argentina
Others

Europe
United Kingdom
Germany
France
Others

Middle East and Africa
Saudi Arabia
UAE
Israel
Others

Asia Pacific

China
India
Australia
South Korea
Others